NEW YORK (Reuters Health) – Contrary to expectations, individual genetic markers don’t add up to a genetic risk score that’s any better than traditional risk factors for predicting…
NEW YORK (Reuters Health) – In patients with chest pain of uncertain origin, emergency department evaluation combining clinical history and N-terminal pro-B-type natriuretic peptide (NT-proBNP) level, without exercise…
NEW YORK (Reuters Health) – With intensive medical therapy, fewer than 5% of patients with asymptomatic carotid stenosis will gain additional benefit from revascularization, according to a report…
NEW YORK (Reuters Health) – Limiting thyroid tests to high-risk women will miss most cases of thyroid dysfunction during pregnancy, randomized trial results show. Furthermore, when low-risk women…
NEW YORK (Reuters Health) – Potassium monitoring can help prevent drug-associated hyperkalemia events in patients with diabetes, according to a report in the January 20th online issue of…
Program Overview The Best Practice Series in Atherosclerosis is a series of 5-minute videos featuring top physicians discussing the best ways to diagnose and treat atherosclerosis based on…
NEW YORK (Reuters Health) – For patients with diabetes and complex multivessel coronary artery disease, the risk of repeat vascularization within one year is elevated 3-fold after percutaneous…
NEW YORK (Reuters Health) – In patients with schizophrenia, clozapine does not seem to increase the risk of cardiovascular death relative to risperidone, despite known differences in cardiometabolic…
NEW YORK (Reuters Health) – Tight glycemic control may increase the risks of mortality and cardiovascular disease, new research suggests. Moderate control, with glycosylated hemoglobin A1c (HbA1c) levels…
NEW YORK (Reuters Health) – In patients with hypertensive nephropathy and metabolic acidosis, alkali treatment reduces tubulointerstitial injury and slows the decline in glomerular filtration rate (GFR), a…